Dixon India (DIXON.NS) traded down -3.48 % during a 24 hours period ending at 11:51 PM Central Europe on Monday 26th. One Dixon India stock can currently be bought for about INR 11,161 on popular exchanges. Current supply of Dixon India stocks is 61.2 mn. Dixon India has a current market capitalization of INR 684.6 bn and approximately INR 3.9 bn worth of Dixon India was traded on exchanges in the last 24 hours. Since last month end, Dixon India has traded -15.85 % down. Simple moving average of last 200 days is at INR 12,087.64. The highest price of past 52 weeks was recorded at INR 15,775 on 11/19/2025. 52 weeks low was at INR 9,600 on 03/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Oil India (OIL.NS) traded down -1.98 % and now trades at INR 454.9. Oil India has a market capitalisation of INR 728.5 bn. Current price/earnings ratio for Oil India is 8.84.

  • Info Edge India (NAUKRI.NS) traded down -2.55 % and now trades at INR 1,196.6. Info Edge India has a market capitalisation of INR 768.9 bn. Info Edge India has a current price to earnings ratio of 50.08.

  • Mazagon Dock Shipbuilders Lt (MAZDOCK.NS) traded down -3.24 % and now trades at INR 1,875. Current market capitalisation for Mazagon Dock Shipbuilders Lt is INR 750.3 bn. Mazagon Dock Shipbuilders Lt has a current price to earnings ratio of 30.06.

  • Max Healthcare Institute (MAXHEALTH.NS) traded down -0.24 % and now trades at INR 835. Max Healthcare Institute has a market capitalisation of INR 793.2 bn. Current price/earnings ratio for Max Healthcare Institute is 54.73. Max Healthcare Institute has emerged as a prominent holding within the Invesco India Mid‑Cap Fund’s portfolio, representing a significant portion of the fund’s exposure to the healthcare sector. The fund’s recent allocations indicate a balanced strategy, combining mid‑cap, large‑cap, and small‑cap positions with a focus on quality, growth‑oriented companies. Max Healthcare’s inclusion reflects the fund’s broader emphasis on sectors with strong fundamentals and attractive valuation profiles. Investors observing the mid‑cap space may view this development as indicative of continued confidence in healthcare as a growth driver, while the fund’s overall performance has demonstrated resilience amid market fluctuations, maintaining a diversified stance that seeks to mitigate downside risk.

  • Icici Lombard General Insura (ICICIGI.NS) traded down -2.51 % and now trades at INR 1,580. Current market capitalisation for Icici Lombard General Insura is INR 795.4 bn. Current price/earnings ratio for Icici Lombard General Insura is 32.22.